Thrombin-induced platelet PAR4 activation: Role of glycoprotein ibandadp

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 4, 2003, Pages 798-804

  Adam, F ^a   Verbeuren, T J ^b   Fauchere J L ^b   Guillin, M C ^a,c   Jandrot Perrus, M ^a  

^a INSERM   (France)

^b BICHAT HOSPITAL   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

ADP; Glycoprotein Ib; Protease activated G protein coupled receptor; Thrombin

Indexed keywords

A1BG PROTEIN, HUMAN; ADENOSINE DIPHOSPHATE; GLYCOPROTEIN; IMMUNOGLOBULIN; PLASMA PROTEIN; PROTEASE-ACTIVATED RECEPTOR 4; PROTEINASE ACTIVATED RECEPTOR 4; PURINE P2 RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y2 RECEPTOR; THROMBIN; THROMBIN RECEPTOR;

ARTICLE; DRUG EFFECT; HUMAN; KINETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION;

ADENOSINE DIPHOSPHATE; BLOOD PROTEINS; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS; KINETICS; PLATELET ACTIVATION; RECEPTORS, PURINERGIC P2; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION; THROMBIN;

EID: 0142228243     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00138.x     Document Type: Article

References (39)

1. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
2. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV, Tarn C, Couglin SR. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-4.
3. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW, Foster DC. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998; 95: 6642-6.
4. Kahn ML, Nakanishi-Matsui M, Shapiro MI, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999; 103: 879-87.
5. Vu TK, Wheaton VI, Hung DT, Charo I, Coughlin SR. Domains specifying thrombin-receptor interaction. Nature 1991; 353: 674-7.
6. Coughlin SR. How the protease thrombin talks to cells. Proc NatlAcad Sci USA 1999; 96: 11023-7.
7. Andersen H, Greenberg DL, Fujikawa K, Xu W, Chung DW, Davie EW. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc Natl Acad Sci USA 1999; 96: 11189-93.
8. Shapiro MJ, Weiss EJ, Faruqi TR, Coughlin SR. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem 2000; 275: 25216-21.
9. Covic L, Gresser AL, Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Bio chemistry 2000; 39: 5458-67.
10. Okumura T, Hasitz M, Jamieson GA. Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface. J Biol Chem 1978; 253: 3435-43.
11. Jamieson GA, Okumura T. Reduced thrombin binding and aggregation in Bernard-Soulier platelets. J Clin Invest 1978; 61: 861-4.
12. Ganguly P, Gould NL. Thrombin receptors of human platelets: thrombin binding and antithrombin properties of glycoprotein I. Br J Haematol 1979; 42: 137-45.
13. De Marco L, Mazzucato M, Masotti A, Fenton JW, Ruggeri ZM. Function of glycoprotein Ib alpha in platelet activation induced by alpha-thrombin. J Biol Chem 1991; 266: 23776-83.
14. Jandrot-Perms M, Rendu F, Caen JP, Levy-Toledano S, Guillin MC. The common pathway for alpha- and gamma-thrombin-induced platelet activation is independent of GPIb: a study of Bernard-Soulier platelets. Br J Haematol 1990; 75: 385-92.
15. Coughlin SR. Protease-activated receptors in vascular biology. Thromb Haemost 2001; 86: 298-307.
16. De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, De Cristofaro R. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. J Biol Chem 2001; 276: 4692-8.
17. Mills DC. ADP receptors on platelets. Thromb Haemost 1996; 76: 835-56.
18. Gachet C, Hechler B, Leon C, Vial C, Leray C, Ohlmann P, Cazanave JP. Activation of ADP receptors and platelet function. Thromb Haemost 1997; 78: 271-5.
19. Cattaneo M, Canciani MT, Lecchi A, Kinlough-Rathbone RL, Packham MA, Mannucci PM, Mustard JF. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood 1990; 75: 1081-6.
20. Kinlough-Rathbone RL, Packham MA, Perry DW, Mustard JF, Cattaneo M. Lack of stability of aggregates after thrombin-induced reaggregation of thrombin-degranulated platelets. Thromb Haemost 1992; 67: 453-7.
21. Faruqi TR, Weiss EJ, Shapiro MJ, Huang W, Coughlin SR. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function. J Biol Chem 2000; 275: 19728-34.
22. Bezeaud A, Denninger MH, Guillin MC. Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin. Eur J Biochem 1985; 153: 491-6.
23. Jandrot-Perrus M, Guillin MC, Nurden AT. Human gamma-thrombin: lack of correlation between a platelet functional response and glyco protein V hydrolysis. Thromb Haemost 1987; 58: 915-20.
24. Clemetson JM, Kyrle PA, Brenner B, Clemetson KJ. Variant Bernard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IX. Blood 1994; 84: 1124-31.
25. Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin. Bio chemistry 1996; 35: 4929-38.
26. + indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
27. Trumel C, Payrastre B, Plantavid M, Hechler B, Viala C, Presek P, Martinson MA, Cazenave JP, Chap H, Gachet C. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PARl-activating peptide through the late activation of phos-phoinositide 3-kinase. Blood 1999; 94: 4156-65.
28. Andrade-Gordon P, Maryanoff BE, Derian CK, Zhang HC, Addo MF, Darrow AL, Eckhardt AJ, Hoekstra WJ, McComsey DF, Oksenberg D, Reynolds EE, Santulli RJ, Scarborough RM, Smith CE, White KB. Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor. Proc Natl Acad Sci USA 1999; 96: 12257-62.
29. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000; 404: 609-13.
30. Jandrot-Perrus M, Clemetson KJ, Huisse MG, Guillin MC. Thrombin interaction with platelet glycoprotein Ib: effect of glycocalicin on thrombin specificity. Blood 1992; 80: 2781-6.
31. De Candia E, De Cristofaro R, De Marco L, Mazzucato M, Picozzi M, Landolfi R. Thrombin interaction with platelet GpIB. role of the heparin binding domain. Thromb Haemost 1997; 77: 735-40.
32. Mazzucato M, Marco LD, Masotti A, Pradella P, Bahou WF, Ruggeri ZM. Characterization of the initial alpha-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation. J Biol Chem 1998; 273: 1880-7.
33. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001; 86: 222-32.
34. Eckly A, Gendrault JL, Hechler B, Cazenave JP, Gachet C. Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation. Thromb Haemost 2001; 85: 694-701.
35. Covic L, Singh C, Smith H, Kuliopulos A. Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome. Thromb Haemost 2002; 87: 722-7.
36. 2+] induced by alpha-thrombin. Biochemistry 1996; 35: 906-14.
37. Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 2000; 275: 6819-23.
38. LaRosa CA, Rohrer MJ, Benoit SE, Barnard MR, Michelson AD. Neutrophil cathepsin G modulates the platelet surface expression of the glycoprotein (GP) Ib-IX complex by proteolysis of the von Willebrand factor binding site on GPIb alpha and by a cytoskeletal-mediated redistribution of the remainder of the complex. Blood 1994; 84: 158-68.
39. Pidard D, Renesto P, Berndt MC, Rabhi S, Clemetson KJ, Chignard M. Neutrophil proteinase cathepsin G is proteolytically active on the human platelet glycoprotein Ib-IX receptor: characterization of the cleavage sites within the glycoprotein Ib alpha subunit. Biochem J 1994; 303: 489-98.